Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $105
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has maintained a Buy rating on Merit Medical Systems (NASDAQ:MMSI) and increased the price target from $94 to $105.
August 28, 2024 | 10:08 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson has maintained a Buy rating on Merit Medical Systems and increased the price target from $94 to $105, indicating confidence in the company's future performance.
The increase in the price target from $94 to $105 by Needham suggests a positive outlook on Merit Medical Systems' future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100